Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Acute Lymphoblastic Leukemia
Age: Between 30 - 70 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required